HIV with non-communicable diseases in primary care in Kibera, Nairobi, Kenya: Characteristics and outcomes 2010-2013

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 109, Issue 7, 2015, Pages 440-446

  Edwards, Jeffrey K ^a   Bygrave, Helen ^a   Van Den Bergh, Rafael ^b   Kizito, Walter ^a   Cheti, Erastus ^a   Kosgei, Rose J ^c   Sobry, Agnès ^a   Vandenbulcke, Alexandra ^a   Vakil, Shobha N ^d   Reid, Tony ^b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MÉDECINS SANS FRONTIÈRES   (Belgium)

^c UNIVERSITY OF NAIROBI   (Kenya)

^d Department of Obstetrics and Gynaecology ^*  (Kenya)

Author keywords

Africa; Chronic kidney disease; Diabetes; HIV; Hypertension; Non communicable diseases

Indexed keywords

ATENOLOL; CHOLESTEROL; EFAVIRENZ; EFAVIRENZ PLUS LAMIVUDINE PLUS TENOFOVIR DISOPROXIL; ENALAPRIL; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; HYDROCHLOROTHIAZIDE; INSULIN; LOPINAVIR PLUS RITONAVIR; METFORMIN; NIFEDIPINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGE; ANTIHYPERTENSIVE THERAPY; ANTIVIRAL THERAPY; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; DIABETIC PATIENT; DIET RESTRICTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INSULIN TREATMENT; KENYA; MAJOR CLINICAL STUDY; MALE; NON COMMUNICABLE DISEASE; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; BLOOD; COMORBIDITY; GLUCOSE BLOOD LEVEL; HIV INFECTIONS; INTEGRATED HEALTH CARE SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; SURVIVOR;

ADULT; ANTI-HIV AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HIV INFECTIONS; HUMANS; HYPERTENSION; KENYA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SURVIVORS;

EID: 84938507233     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trv038     Document Type: Article

References (31)

1. Samb B, Desai N, Nishtar S et al. Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries. Lancet 2010;376:1785-97.
2. Post WS. Predicting and preventing cardiovascular disease in HIV-infected patients. Top Antivir Med 2011;19:169-73.
3. Fedele F, Bruno N, Mancone M. Cardiovascular risk factors and HIV disease. AIDS Rev 2011;13:119-29.
4. Kalra S, Agrawal N. Diabetes and HIV: current understanding and future perspectives. Curr Diab Rep 2013;13:419-27.
5. Fabian J, Naicker S, Goetsch S, Venter WDF. The clinical and histological response of HIV-associated kidney disease to antiretroviral therapy in South Africans. Nephrol Dial Transplant 2013;6:1543-54.
6. Council on Foreign Relations. The Emerging Global Crisis Noncommunicable Diseases in Low- and Middle-Income Countries. 2014. http://www.cfr.org/diseases-noncommunicable/emerging-global-health-crisis/p33883 [accessed 11 December 2014].
7. Remais JV, Zeng G, Li G et al. Convergence of non-communicable and infectious diseases in low- and middle-income countries. Int J Epidemiol 2013;42:221-7. http://www.ije.oxfordjournals.org/cgi/doi/10.1093/ije/dys135 [accessed 24 November 2014].
8. Levitt NS, Steyn K, Dave J, Bradshaw D. Chronic noncommunicable diseases and HIV-AIDS on a collision course: relevance for health care delivery, particularly in low-resource settings--insights from South Africa. Am J Clin Nutr 2011;94:1690S-6S.
9. Peck RN, Shedafa R, Kalluvya S et al. Hypertension, kidney disease, HIV and antiretroviral therapy among Tanzanian adults: a cross-sectional study. BMC Medicine 2014;12:125.
10. BeLue R, Okoror TA, Iwelunmor J et al. An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Global Health 2009;5:10.
11. Desgroppes A, Sophie T. Kibera: The biggest slum in Africa? Cahiers de l'Afrique de l'Est 2011;44:23-34.
12. Dalal W, Feikin DR, Amolloh M et al. Home-based HIV testing and counseling in rural and urban Kenyan communities. J Acquir Immune Defic Syndr 2013;62:e47-e54.
13. Sobry A, Kizito W, Van den Bergh R et al. Caseload, management and treatment outcomes of patients with hypertension and/or diabetes mellitus in a primary health care programme in an informal setting. Trop Med Int Health 2014;19:47-57.
14. Wyatt CM, Schwartz GJ, Owino-Ong'or W et al. Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance. PLoS ONE 2013;8:e69601.
15. Fliser D, Laville M, Covic A et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1:definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 2012;27:4263-72.
16. Lauritsen JM, Bruus M. EpiData Entry (version 3.1). A comprehensive tool for validated entry and documentation of data. The EpiData Association, Odense Denmark 2008. http://www.epidata.dk/index.htm [accessed 20 March 2013].
17. FUCHIA. Follow-Up and Care of HIV Infection and Aids software program (version 1.7.0). Epicentre, Paris, France 2011.
18. Centers for Disease Control and Prevention. Epi Info 7.1.2. 2013:1-3. http://wwwn.cdc.gov/epiinfo/7/ [accessed 20 March 2013].
19. Zulu EM, Beguy D, Ezeh AC et al. Overview of migration, poverty and health dynamics in Nairobi City's slum settlements. J Urban Health 2011;88:185-99.
20. Nüesch R,Wang Q, Elzi L et al. Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). J Acquir Immune Defic Syndr 2013;62:396-404.
21. RyomL, Mocroft A, KirkOet al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D Study. J Infect Dis 2013;207:1359-69.
22. Yahaya I, Uthman OA, Uthman MMB. Interventions for HIV-associated nephropathy. Cochrane Database Syst Rev 2013. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007183.pub3/abstract [accessed 24 November 2014].
23. Fabian J, Naicker S. HIV and kidney disease in sub-Saharan Africa. Nat Rev Nephrol 2009;5:591-8.
24. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012;379:165-80.
25. Yirsaw B. Chronic kidney disease in sub-Saharan Africa: Hypothesis for research demand. Ann Afr Med 2012;11:119.
26. Arogundade FA, Barsoum RS. CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis 2008;51:515-23.
27. Katz IJ, Gerntholtz T, Naicker S. Africa and nephrology: the forgotten continent. Nephron Clin Pract 2011;117:c320-7.
28. Edwards JK, ThiongóA, Van den Bergh R et al. Preventable but neglected: rickets in an informal settlement, Nairobi, Kenya. Pub Health Action 2014;4:122-7.
29. van de Vijver S, Oti SO, Agyemang C. Prevalence, awareness, treatment and control of hypertension among slum dwellers in Nairobi, Kenya. J Hypertens 2013;31:1018-24.
30. Ayah R, Joshi MD, Wanjiru R et al. A population-based survey of prevalence of diabetes and correlates in an urban slum community in Nairobi, Kenya. BMC Public Health 2013;13:371.
31. Harries AD, Zachariah R, Maher D. The power of data: using routinely collected data to improve public health programmes and patient outcomes in low- and middle-income countries. Trop Med Int Health 2013;18:1154-6.